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Abstract
Background: Human rhinoviruses (HRV) cause the majority of colds and trigger exacerbations of chronic lower airway
diseases. Airway epithelial cells are the primary site for HRV infection and replication, and the initiation of host
inflammatory responses. At present, the molecular mechanisms that underpin HRV responses in airway epithelial cells
are incompletely understood. The aim of this study was to employ microarray profiling, upstream regulator analysis,
and siRNA mediated gene silencing to further our understanding of the role of interferon regulatory factor 7 (IRF7) in
this response.
Methods: Primary human bronchial epithelial cells (HBE) where transfected with siRNA that targets IRF7 or a non-
silencing control (all-star control) using Lipofectamine. The cells were allowed to recover, and then cultured in the
presence or absence of HRV-16 for 24 h. Global patterns of gene expression were profiled on microarrays. A subset of
genes identified in the microarray study were validated at the mRNA and/or protein level using real time RT-qPCR,
ELISA, and western blots.
Results: Hundreds of genes were upregulated in HBE during HRV infection. Pathways analysis demonstrated that
these genes were mainly involved in type I and II interferon signaling, RIG-I/MDA5 signaling, antigen
processing and presentation, and apoptosis. Upstream regulator analysis of these data suggested that IRF7 was a
major molecular driver of this response. Knockdown of IRF7 reduced the HRV-driven upregulation of genes involved in
antiviral responses (interferon signaling, Toll-like receptor signaling, NOD-like receptor signaling, RIG-I/MDA5 signaling),
and increased the expression of genes that promote inflammation (e.g. CXCL5, IL-33, IL1RL1) and the response to
oxidative stress. However, the majority of genes that were perturbed by HRV in HBE cells including those that are
known to be regulated by IRF7 were insensitive to IRF7 knockdown. Upstream regulator analysis of the part of the
response that was insensitive to IRF7 knockdown suggested it was driven by NF-κB, STAT1, STAT3, and IRF1.
Conclusions: Our findings demonstrate that IRF7 regulates the expression of genes involved in antiviral immunity,
inflammation, and the response to oxidative stress during HRV infections in HBE cells, and also suggests that other
transcription factors play a major role in this response.
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Background
Human rhinovirus is a positive sense, single-strand RNA
virus from the Picornavirus family. It causes the majority
of colds, and it also triggers exacerbations of asthma,
chronic obstructive pulmonary disease, and cystic fibro-
sis [1]. More than 150 strains of HRV have been identi-
fied, and these have been classified into three species (A,
B, C) based on genome sequencing data [2]. Airway epi-
thelial cells are the primary site for rhinovirus infection
and replication. Depending on the serotype of HRV, cell
entry is mediated by binding to the receptors ICAM-1
(major group), low-density-lipoprotein receptor family
members (minor group), or cadherin-related family
member 3 (CDHR3 for HRV-C) [3].
Host responses to HRV are thought to be initiated
when viral proteins and nucleic acids trigger pathogen
recognition receptors (PRR) of the innate immune sys-
tem (TLR2, TLR3, TLR7, TLR8, MDA5, RIG-I) [4–6].
PRR signaling triggers intracellular signaling cascades
that converge on the IRF and NF-κB family of transcrip-
tion factors, which in turn activate interferon-induced
antiviral and proinflammatory gene expression programs
respectively. In epithelial cells, interferon programs are
mainly activated via TLR3, MDA5, and RIG-I signaling
[4–6]. IRF7 plays a central role in the activation of in-
nate antiviral responses by controlling the transcription
of type I and III interferon genes [7]. Type I interferon
signaling in turn upregulates IRF7 expression, thereby
providing positive feedback amplification of the antiviral
response [8]. The interferon system plays a crucial role
in antiviral defence by upregulating a set of effector mol-
ecules (e.g. Mx1, OAS, PKR, ISG15), which induce a ro-
bust antiviral state in infected and neighbouring cells
preventing the spread of infection [9]. The importance
of IRF7 in antiviral immunity was clearly demonstrated
in IRF7 deficient mice, which are highly susceptible to
viral infections [10]. Recent data in humans indicates
that null mutations in IRF7 are associated with suscepti-
bility to severe, life-threatening influenza [11].
Although it is well established that IRF7 is a master
regulator of the antiviral response, the function (or re-
dundancy thereof ) of IRF7 can vary markedly depending
on the cell type and the virus [12]. We reported that ex-
pression of IRF7 was upregulated in nasal epithelial
scrapings from human adults after experimental infec-
tion with HRV-16 [13]. Employing a computational ana-
lysis of gene expression profiling data derived from nasal
wash samples, we also showed that IRF7 was a major
hub, connecting interferon-related gene networks during
picornavirus-induced asthma exacerbations in children
[14]. Lewis et al. reported that expression of IRF7 was
upregulated in nasal aspirates from asthmatic children
during natural colds [15]. Notably, all of the above stud-
ies focused on expression levels of IRF7; this is the first
study to perform gene silencing experiments in HBE to




The following reagents were purchased from the indi-
cated suppliers: Ham’s F-12 medium, Eagle’s minimal es-
sential medium, Hank’s balanced salt solution (HBSS),
penicillin-streptomycin-amphotericin B, L-glutamine,
TRIzol reagent, sodium pyruvate, nonessential amino
acids, gentamicin, fetal bovine serum (FBS), dNTPs, oli-
go(dT), random hexamers, and Superscript III from Invi-
trogen Life Technologies (Burlington, Ontario, Canada).
Bronchial epithelial cell growth medium (BEGM) was
from BioWhittaker (Walkersville, MD). Gene expression
kits for GAPDH, IL-6, CXCL5, and HERC5 were from
Applied Biosystems (Foster City, CA); antibody pairs for
CCL5, CXCL5, and CXCL10, as well as recombinant
standards for each assay were from R&D Systems (Min-
neapolis, MN); TaqMan master mix and complete prote-
ase inhibitor cocktail tablets were from Roche
Diagnostics (Laval, Quebec, Canada); western blot anti-
body for IRF7 was from BioLegend (San Diego, CA),
while the viperin antibody was from Abcam (Toronto,
ON). All other chemicals were purchased from Sigma-
Aldrich (St. Louis, MO).
Primary epithelial cell culture
Normal human lungs not used for transplantation were
obtained from a tissue retrieval service (International
Institute for the Advancement of Medicine, Edison, NJ).
Primary HBE cells from a total of 9 donors (4 male; age
range 13–63 years) were used for the current studies. All
donors died from head trauma or stroke, and none of
the donors had any inflammatory lung disease. Written
informed consent was obtained from responsible next of
kin for tissues to be used for either transplant or for re-
search. Approval to use recovered organs for these stud-
ies was obtained from the Conjoint Health Research
Ethics Board of the University of Calgary. Primary HBE
cells were obtained by protease digestion of dissected
airways as previously described [16]. HBE cells were
grown on six-well culture plates in BEGM. Hydrocorti-
sone was removed from the medium 24 h prior to
stimulation and all stimulations were performed in this
hydrocortisone-free medium.
Virus
WI-38 cells were purchased from the American Type
Culture Collection (Manassas, VA). HRV-16 viral stocks
were propagated in WI-38 cells and purified by centrifu-
gation through sucrose to remove ribosomes and soluble
factors of WI-38 origin as previously described [17].
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HBE cells were infected with 105.5 50 % tissue culture-
infective dose (TCID50) U/ml, which equates (approxi-
mately) to a multiplicity of infection of 1.
RNA extraction and real-time RT-qPCR
Total cellular RNA was extracted from cultured epithe-
lial cells with TRIzol (1 ml per 10 cm2) as previously de-
scribed [18]. Yield of RNA was quantified based upon
absorbance at 260 nm. RNA was DNase treated with
DNase I (Ambion, Austin, TX) and then requantified.
One μg of RNA was reverse transcribed with both Oligo
dT and random hexamers with Superscript III, followed
by PCR amplification in the presence of specific forward
and reverse primers and fluorescently labeled probes for
each gene of interest. Gene expression for CXCL10,
CCL5, Viperin, IL-6, CXCL5, and HERC5 were quanti-
fied using the Applied Biosystems Model 7900 Sequence
Detector (Foster City, CA). Analysis of the housekeeping
gene GAPDH was performed on each sample using a
primer and probe kit obtained from Applied Biosystems.
Fold induction of each gene was calculated using the for-
mula 2-ΔΔCT as previously described [19]. Primers and
probes for CXCL10, CCL5 and viperin were as follows:
CXCL10 forward primer 5′-GAAATTATTCCTGCAA
GCCAATTT-3′; reverse primer 5′-TCACCCTTCT
TTTTCATTGTAGCA-3′; probe 5′-FAM-TCCACGTG
TTGAGATCA-MGB-3′, CCL5 forward primer 5′-




reverse primer 5′- GCGCATATATTCATCCAGAATA
AGG-3′; probe 5′-FAM-ACCAGAAGATGAAAGACT-
MGB-3′. Gene expression kits were purchased from Ap-
plied Biosystems for IL-6 (Hs00985639_m1), CXCL5
(Hs01099660_g1), and HERC5 (Hs00180943_m1).
ELISAs
CXCL10, CCL5 and CXCL5 protein levels were assayed
by enzyme-linked immunosorbent assay using matched
antibody pairs (R&D Systems, Minneapolis, MN).
siRNA knockdown of IRF7
Subconfluent HBE cells were transfected with either 10
nM of a siRNA targeted to IRF7 or to a nontargeting
siRNA, all-star control (Qiagen, Toronto, ON) for 24 h at
37 °C using Lipofectamine RNAiMAX (Life Technologies)
in BEGM without antibiotics. After transfection, medium
was changed to BEGM without hydrocortisone and cells
were allowed to recover for 24 h. Cells were then infected
with HRV-16, and supernatants, whole-cell lysates and
total RNA were collected 24 h post infection. The specific
forward siRNA sequences used were as follows: IRF7
siRNA #1, 5′-CCCGAGCTGCACGTTCCTATA-3′; IRF7
siRNA #2, 5′-CTGGAAGCACTTCGCGCGCAA-3′.
Western blots
After stimulation, cells were washed with HBSS and
then scraped in lysis buffer (1 % Triton X-100, 1X mini
complete, 1 mM PMSF, 2 mM sodium orthovanadate,
20 mM sodium pyrophosphate, and 50 mM sodium
fluoride). Lysates were incubated on ice for 10 min, fro-
zen at −80 °C, thawed, sonicated, and centrifuged at
10,000 × g for 5 min at 4 °C. Protein concentrations for
the Triton X-100-soluble lysates were quantified using a
DC Protein Assay (Bio-Rad, Montreal, Quebec, Canada).
Equivalent amounts of protein were separated by SDS-
PAGE, and proteins were then transferred to a nitrocel-
lulose membrane. Membranes were blocked with 5 %
skim milk for 1 h and probed with either 1 μg/mL of the
IRF7 antibody or a 1:1000 dilution of the viperin anti-
body overnight at 4 °C. Membranes were washed and
then incubated for 1 h with a 1:10,000 dilution of horse-
radish peroxidase-conjugated anti-mouse Ig antibody
(Jackson ImmunoResearch Laboratories, Inc., West
Grove, PA). Proteins were visualized with a Pierce ECL
substrate reagent (Thermo Scientific, Rockford, IL).
Equal loading was further determined probing with an
antibody against GAPDH.
Gene expression profiling
Total RNA samples were shipped on dry ice to Expres-
sion Analysis Inc. (Durham, NC). Purified RNA was
quantified using a Nanodrop spectrophotometer and
quality was determined using the Agilent (Santa Clara,
CA) 2100 Lab-on-a-Chip System. The RNA samples
were processed using the Enzo Single Round RNA Amp-
lification and Biotin Labeling System (Enzo, New York,
NY), and hybridized to Primeview microarrays (Affyme-
trix, Santa Clara CA). The raw microarray data is avail-
able at the Gene Expression Omnibus repository under
accession GSE70190.
The microarray data was analyzed in R software for
statistical computing (https://www.r-project.org/). The
quality of the microarray data was assessed with Array-
QualityMetrics [20]. The data was preprocessed employ-
ing the RMA algorithm [21]. A custom chip description
file (primeviewhsentrezg, version 19) was used to map
probe sets to genes [22]. The data was filtered to differ-
entiate between relevant gene expression signals and
noise [23]. Differentially expressed genes were identified
using Linear models for microarray data (LIMMA), with
False Discovery Rate (FDR) control for multiple testing
[24]. Pathways analysis was performed using InnateDb.
Upstream regulators were identified using Ingenuity
Systems software [25]. The IRF7 gene network was
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reconstructed using experimentally supported findings
from the Ingenuity Systems Knowledgebase [14].
Statistical analysis
For assessments of mRNA and protein expression for in-
dividual genes of interest, normally distributed data were
analyzed using one-way analysis of variance (ANOVA)
with student Newman-Keuls post hoc analysis. Analysis
of paired comparisons were performed using t-tests.
Data that were not normally distributed were analyzed
using Kruskal-Wallis ANOVA followed by Wilcoxon
matched-pairs signed-rank test. Statistical hypotheses
were two-sided and values of p < 0.05 were considered
significant.
Results
Rhinovirus-induced gene expression patterns in human
bronchial epithelial (HBE) cells
Primary HBE cells from 5 donors were transfected with
siRNA that targets IRF7 or a non-silencing siRNA con-
trol (all-star control). The HBE cells were allowed to re-
cover for 24 h, and then they were exposed to HRV or
medium control for another 24 h. As illustrated in Fig. 1,
HRV induced the expression of IRF7 protein in HBE
cells that were transfected with control reagents (all-star
control siRNA, lipid reagent alone, medium only), but
not in HBE cells that were transfected with siRNA re-
agents that target IRF7 (siRNA #1, siRNA #2). Of note,
IRF7 protein was not induced by the all-star control
siRNA in HBE cells in the absence of HRV exposure.
Next, global patterns of gene expression were profiled
on microarrays. Initially, we analyzed the data pertaining
to the response to HRV in HBE cells transfected with
the all-star control. As illustrated in Fig. 2, 437 genes
were upregulated in the response and 139 genes were
downregulated (False Discovery Rate (FDR) < 0.05,
Additional file 1). The biological function of the differen-
tially expressed genes was interrogated using InnateDb.
The data showed the upregulated genes were mainly in-
volved in type I and II interferon signaling, RIG-I/
MDA5 signaling, antigen processing and presentation,
and apoptosis (Additional file 2). The downregulated
genes were not strongly enriched for immune-related
pathways, therefore we utilized the Gene Ontology (GO)
database to interrogate their function. This analysis
showed that the downregulated genes were enriched
with the GO biological process term epithelial develop-
ment (GO0060429; ALDH3A2, CTGF, DKK1, EMP1,
ERRFI1, INSR, JAG1, KRT15, PTHLH, SCEL, SOX21;
adjusted p-value = 0.0079).
IRF7 is a putative molecular driver of interferon-induced
gene networks
Upstream regulator analysis was employed to infer the
molecular drivers that give rise to HRV-induced gene
expression patterns in HBE cells (transfected with the
all-star control) [25]. In this analysis, the differentially
expressed genes from Fig. 2 were tested for enrichment
of downstream target genes of known transcriptional
regulators and other signal transduction pathways. As il-
lustrated in Table 1, the most significant candidate
drivers were IFNG, IFNA2, IRF7, TNF, and IFNL1. Not-
ably, IRF7 was the only driver amongst these candidates
that was also upregulated in the response (Additional file
1). To illustrate the role of IRF7 in the regulation of
HRV responses, we utilized experimentally supported
findings from the Ingenuity Systems database to recon-
struct the IRF7 network [14]. The resulting network is
shown in Fig. 3.
Fig. 1 Knockdown of IRF7 protein in HBE cells. HBE cells were
transfected with the transfection reagent only (lipid reagent alone), the
all-star control siRNA (control siRNA), or two independent siRNAs that
target IRF7 (siRNA #1, siRNA #2). The cells were allowed to recover, and
then exposed to HRV. Protein expression was measured by Western
Blot. Data are representative of n = 4
Fig. 2 Gene expression patterns in HRV-induced HBE cells. HBE
cells from 5 donors were transfected with a non-silencing siRNA (all-
star control), allowed to recover, and then cultured in the presence or
absence of HRV for 24 h. Gene expression was profiled on microarrays.
The dashed horizontal line indicates FDR < 0.05
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Knockdown of IRF7 perturbs HBE responses to rhinovirus
We next examined the impact of IRF7 knockdown on
the HRV response. Gene expression patterns were com-
pared between HRV-induced HBE cells transfected with
IRF7-siRNA #1 versus the all-star control. The data
showed that knockdown of IRF7 resulted in decreased
expression of 447 genes, and increased expression of 181
genes (Additional file 3, Fig. 4). The downregulated
genes were mainly involved in type I and II interferon
signaling, Toll-like receptor signaling, NOD-like recep-
tor signaling, and RIG-I/MDA5 signaling (Additional file
4). As a supplementary analysis, we also examined the
function of the downregulated genes after removal of
known IRF7 target genes. These residual genes were as-
sociated with NOD-like receptor signaling pathways,
trafficking of connexons, and metabolic pathways (Add-
itional file 5). The upregulated genes were involved in
the response to oxidative stress (GO:0006979; ADA,
ARL6IP5, CYGB, FOS, MMP14, NET1, NQO1, PLK3,
SNCA, TRPC6, UCP2; p-value = 0.0004) and inflamma-
tion (GO:0050729; ADORA2B, C3, IL1RL1, IL33, SER-
PINE1, TNFSF11; p-value = 0.0005), although it is
noteworthy that these findings were not significant after
adjustment of the p-values for multiple testing.
We next wanted to investigate the part of the HRV re-
sponse that was insensitive to IRF7 knockdown. In HBE
cells that were transfected with the all-star control
siRNA, 576 genes were differentially expressed after
HRV exposure, but only 177 of these genes (31 %) were
sensitive to IRF7 knockdown (Fig. 5). Moreover, the
IRF7 gene network depicted in Fig. 3 contained 86
genes, and only 41 of these (47 %) were sensitive to IRF7
knockdown (Fig. 4, Additional file 6). We analyzed these
HRV responsive genes that were insensitive to IRF7
knockdown using upstream regulator analysis. The data
showed the highest ranking candidate transcription fac-
tors driving this response were NF-κB, STAT1, STAT3,
and IRF1 (Additional file 7).
Validation of the microarray findings
To confirm the findings from the microarray experi-
ment, a subset of genes were selected for validation at
the mRNA and/or protein levels. As illustrated in Fig. 6,
Reverse Transcription quantitative PCR (RT-qPCR) ana-
lysis demonstrated that knockdown of IRF7 in HBE cells
followed by exposure to HRV resulted in reduced ex-
pression of CCL5, CXCL10, HERC5, IL-6, RSAD2
(viperin), and increased expression of CXCL5, and this
was consistent with the microarray data (Additional file
3). Expression levels of CCL5, CXCL5, CXCL10, and
viperin were also examined at the protein level (Fig. 7).
These data confirmed that the mRNA expression
changes observed upon siRNA knockdown were associ-
ated with parallel changes at the protein level, although
Table 1 Identification of molecular drivers of gene expression patterns in HRV-induced HBE cells
Upstream regulator Predicted activation state Activation Z-score P-value of overlap
IFNG Activated 10.890 1.08E-90
IFNA2 Activated 8.106 9.79E-85
IRF7 Activated 8.284 1.76E-71
TNF Activated 9.828 3.92E-67
IFNL1 Activated 6.936 1.02E-62
IFNAR Activated 6.306 5.99E-55
STAT1 Activated 6.317 2.32E-54
IFNB1 Activated 5.436 3.64E-50
STAT3 Activated 4.185 9.25E-48
IRF1 Activated 5.780 6.24E-46
NFkB (complex) Activated 6.850 1.41E-39
TLR3 Activated 5.327 5.45E-39
IL1B Activated 6.926 1.29E-37
CD40LG Activated 4.739 8.56E-35
OSM Activated 5.463 1.99E-34
TLR4 Activated 5.165 3.64E-33
NKX2-3 Inhibited −7.703 1.50E-58
MAPK1 Inhibited −6.867 5.29E-58
TRIM24 Inhibited −6.002 1.67E-44
IL1RN Inhibited −6.336 2.84E-35
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these changes were more pronounced with siRNA #2
than with siRNA #1.
Discussion
IRF7 is a master regulator of type I interferon gene
expression and antiviral immunity, but the role of
IRF7 in HBE responses to HRV has not been previ-
ously investigated. Employing microarray profiling we
showed that hundreds of genes were upregulated in
HBE upon HRV infection. Upstream regulator analysis
[25] suggested that IRF7 was a major molecular driver
of this response. We then showed that knockdown of
IRF7 in HBE altered HRV responses, by decreasing
the upregulation of genes involved in type I and II
interferon signaling and innate immunity (toll-like re-
ceptor signaling, NOD-like receptor signaling, RIG-I/
Fig. 3 IRF7 is a putative molecular driver of HBE responses to HRV. Differentially expressed genes were identified in HRV-induced HBE cells
(Fig. 2), and then the wiring diagram of the IRF7 gene network was reconstructed from these data employing experimentally supported
findings from published studies. Solid and dashed lines indicate direct and indirect interactions respectively. Genes colored red were
upregulated in the response and genes colored green were downregulated
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MDA5 signaling), and increasing the expression of
genes that promote inflammation (C3, CXCL5, IL-33,
IL1RL1) and the response to oxidative stress. We vali-
dated a subset of the differentially regulated genes
(CCL5, CXCL5, CXCL10, HERC5, IL-6, RSAD2/
viperin) at the mRNA and/or protein levels, thus con-
firming the findings from the microarray experiment.
The data also showed that only around 30 % of the
HRV responsive genes and half of known IRF7 target
genes were sensitive to IRF7 knockdown, and these
genes exhibited modest fold changes in our experi-
ments (less than 2 fold), suggesting that other tran-
scription factors are likely to be important in the
regulation of interferon gene expression programs in
HBE cells. Upstream regulator analysis of the part of
the HRV response that was insensitive to IRF7 knock-
down suggested roles for NF-κB, STAT1, STAT3, and
IRF1 in the regulation of the response. Overall, our
findings demonstrate that IRF7 regulates the expres-
sion of genes involved in antiviral immunity, inflam-
mation, and the response to oxidative stress in HBE
cells during HRV infections, and also suggest that
additional transcription factors play a major role in
the regulation of this response.
We showed that the upregulation of CCL5,
CXCL10, HERC5, IL-6, and RSAD2 by HRV was re-
duced by IRF7 knockdown in HBE cells. Regulation
of these genes by IRF7 has been previously reported
in other contexts [26–29]. CCL5 (RANTES) is a po-
tent chemoattractant for T cells, monocytes, and eo-
sinophils. CCL5 was upregulated in nasal wash
samples from wheezing, HRV-infected infants in com-
parison to their nonwheezing counterparts [30].
CXCL10 is chemotactic for T cells and natural killer
cells, and was strongly upregulated in airway epithe-
lial cells during HRV infections [31]. CXCL10
promotes airways inflammation and airways hyperre-
sponsiveness in mouse models of asthma [32]. HERC5
is an E3 protein ligase that mediates ISGylation of
protein targets. It catalyzes the conjugation of ISG15
onto IRF3, which inhibits the ubiquitination and deg-
radation of IRF3 by preventing IRF3 from interacting
with Pin1. This results in the sustained activation of
IRF3 and the antiviral response [33]. IL-6 promotes
the acute phase response, stimulates T cell responses
and antibody production, and it is increased during
symptomatic rhinovirus infections [34]. IRF7 was re-
quired for IL-6 production by poly (I-C) stimulated
THP-1 monocytes [29]. In contrast, IRF7 was dispens-
able for IL-6 production in plasmacytoid and myeloid
dendritic cells stimulated by TLR7 or TLR9 ligands
[10]. Viperin (RSAD2) is an antiviral protein that can
inhibit influenza budding from the plasma membrane
by interfering with lipid rafts [35]. Knockdown of
viperin in airway epithelial cells increased HRV repli-
cation [13]. It is not possible to determine from our
experiments if IRF7 regulates HRV-induced airway in-
flammatory responses in vivo, however, Girkin et al.
showed that intranasal delivery of siRNA that targets
IRF7 reduced the infiltration of neutrophils and mac-
rophages in the bronchoalveolar lavage fluid of non-
allergic mice after HRV-1B infection [36]. Taken to-
gether, these studies suggest that IRF7 regulates HRV-
Fig. 4 Knockdown of IRF7 perturbs HBE cells responses to HRV.
HBE cells from five donors were transfected with siRNA that targets
IRF7 (siRNA #1) or the non-silencing all-star control, allowed to recover,
and then exposed to HRV for 24 h. Gene expression was profiled on
microarrays. The data was compared between HRV-induced cells
treated with IRF7-siRNA #1 versus the all-star control. Genes with
negative values on the horizontal axis were decreased by IRF7
knockdown, whereas those with positive values were increased.
The black triangles show the location of genes from the IRF7
network. The dashed horizontal line indicates FDR < 0.05
Fig. 5 Most HRV responsive genes were insensitive to IRF7
knockdown. Venn diagram illustrating the overlap between those
genes that were modulated by HRV (from Fig. 2) versus those
that were sensitive to IRF7 knockdown (from Fig. 4)
Bosco et al. BMC Genomics  (2016) 17:76 Page 7 of 12
Fig. 6 (See legend on next page.)
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induced gene network patterns and ensuing cellular
immune responses in the airways.
In contrast to genes involved in antiviral defense,
knockdown of IRF7 resulted in increased expression
of CXCL5, IL-33, and IL1RL1. CXCL5 (ENA-78) is
important for neutrophil homeostasis and recruitment
to the lung during infections [37]. IL-33 is a nuclear-
associated alarmin expressed in the airway epithelium.
It signals through the ST2 receptor (IL1RL1), which
is highly expressed on T-helper type 2 (Th2) lympho-
cytes and group 2 innate lymphoid cells (ILC2s) [38].
IL-33 is upregulated in the airways during HRV-
induced asthma exacerbations [39]. Moreover, super-
natants from HRV-infected epithelial cells stimulate
the production of Th2 cytokines by Th2 and ILC2
cells in an IL-33 dependant manner [39]. IRF7 binds
to the IL-33 promoter and regulates IL-33 transcrip-
tion in human monocyte THP-1 cell lines [40]. Given
that IL-33 is a potent driver of asthmatic ILC2 and
Th2 responses, and we found that knockdown of
IRF7 results in upregulation of IL-33, this suggests
the hypothesis that promoting IRF7 responses during
asthma exacerbations may have a dual beneficial ef-
fect of increasing antiviral immunity and supressing
IL-33 responses.
Knockdown of IRF7 decreased expression of genes in-
volved in Nod-like receptor signaling, and increased
expression of genes involved in the response to oxidative
stress (e.g. cytoglobin (CYGB), NAD(P)H:quinone ac-
ceptor oxidoreductase 1 (NQO1), alpha-synuclein
(SNCA), short transient receptor potential channel 6
(TRPC6)) [41–44]. In this context it is noteworthy that
the generation of reactive oxygen species during HRV
infection compromises epithelial barrier function, and
this can lead to secondary bacterial infections [45, 46].
HRV infection stimulates the epithelial production of re-
active oxygen species by triggering the dsRNA receptor
Nod-like receptor X-1 (NLRX-1) [47]. Cross-talk be-
tween oxidative stress pathways and IRF7 signaling was
reported in the context of respiratory syncytial virus in-
fection [48]. The role of IRF7 in the regulation of Nod-
like receptor signaling and oxidative stress pathways
during HRV infections merits further investigation in
follow-up studies.
(See figure on previous page.)
Fig. 6 Validation of the microarray data at the mRNA level. HBE cells were transfected with the all-star control siRNA, or two independent siRNA
reagents that target IRF7 (siRNA #1, siRNA #2). The cells were allowed to recover, and then exposed to HRV for 24 h. Gene expression levels were
measured by real time RT-qPCR. The data for siRNA #1 and siRNA #2 are expressed as percent mRNA response relative to the all-star control. Data
are mean ± SEM from 4 experiments. Asterisks show significant differences compared to the all star control siRNA treatment. Hashmarks (#)
indicate significant differences between siRNA#1 and siRNA#2
Fig. 7 Validation of the microarray data at the protein level. HBE cells were transfected with the all-star control siRNA, or two independent siRNA
reagents that target IRF7 (siRNA #1, siRNA #2). The cells were allowed to recover, and then exposed to HRV for 24 h. Protein levels for CCL5,
CXCL5, CXCL10 were measured by ELISA and are shown as mean ± SEM from 4 experiments. Asterisks show significant differences compared to
the all star control siRNA treatment. Expression of viperin protein was assessed by western blot. Data are representative of 4 such experiments
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Upstream regulator analysis demonstrated that IRF7
was the most significant candidate molecular driver that
was upregulated in the HRV response. However, our
siRNA studies showed that only about 30 % of the HRV
responsive genes and half of known IRF7 target genes
were sensitive to IRF7 knockdown. Whilst variable and
incomplete knockdown and the potential for non-
specific activation of antiviral pathways is a well-known
limitation of siRNA technology, an alternative explan-
ation of the data is that other transcription factors may
be playing a role. Employing upstream regulator analysis
we showed that NF-κB, STAT1, STAT3, and IRF1 were
candidate drivers of the part of the HRV response that
was insensitive to IRF7 knockdown. In this context it is
noteworthy we have reported that HRV-induced upregu-
lation of CXCL10 in bronchial epithelial cells was
dependent on IRF1 [49]. Wang et al. have also reported
that knockdown of IRF3 abrogated HRV-induced type I
and III interferon responses in BEAS-2B epithelial cells
[5]. Taken together, these observations suggest that
interferon responses in HRV-induced HBE cells can be
variably mediated by interactions between IRF1, IRF3,
and IRF7.
This study has limitations that should be acknowl-
edged. First, the gene expression studies were conducted
at a single time point post infection (24 h), so it was not
possible to determine the role of IRF7 in the kinetics of
the response. Second, siRNA-mediated gene silencing
was used to investigate the role of IRF7 in the regulation
of gene expression patterns, and from this data it was
not possible to determine if IRF7 was playing a direct or
indirect regulatory role. Third, prior knowledge was used
to infer the molecular drivers of the response, and this
analysis cannot reveal novel molecular drivers. This lat-
ter limitation can be addressed using unbiased data-
driven algorithms to infer the molecular drivers of the
response [50]. Although we acknowledge that the use of
epithelial cells grown in submersion culture, as opposed
to differentiated air-liquid interface cultures, may be
considered a limitation of the current study, we believe
that the data obtained are still highly relevant. This is
based on the observation that the profile of HRV-
upregulated genes in these cultures, in both the present
and in an earlier study [51], aligns closely with those ob-
served in nasal epithelial scrapings from individuals ex-
perimentally infected with HRV in vivo [13].
Conclusion
Our study demonstrates that IRF7 regulates the expres-
sion of antiviral, inflammatory and oxidative stress re-
sponse pathways during HRV infections in HBE cells,
and suggests that additional transcription factors play an
important role in the response.
Availability of supporting data
The microarray data are available at the Gene Expres-
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